|
Quotes & Info
|
| SRPT > SEC Filings for SRPT > Form 8-K on 5-Jun-2012 | All Recent SEC Filings |
5-Jun-2012
Change in Directors or Principal Officers
On June 1, 2012, Peter Linsley, Ph.D., Senior Vice President and Chief Scientific Officer of AVI BioPharma, Inc. (the "Company"), effected his resignation from his position with the Company. The Company had previously disclosed Dr. Linsley's intention to resign from his position with the Company in a Form 8-K filed April 12, 2012.
|
|